nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—SCN9A—prostate gland—prostate cancer	0.00503	0.155	CbGeAlD
Mepivacaine—SCN4A—prostate gland—prostate cancer	0.00449	0.138	CbGeAlD
Mepivacaine—SCN3A—prostate gland—prostate cancer	0.00349	0.108	CbGeAlD
Mepivacaine—SCN4A—renal system—prostate cancer	0.00306	0.0943	CbGeAlD
Mepivacaine—Lidocaine—CYP2C18—prostate cancer	0.00301	0.178	CrCbGaD
Mepivacaine—SCN8A—testis—prostate cancer	0.00252	0.0777	CbGeAlD
Mepivacaine—SCN3A—renal system—prostate cancer	0.00238	0.0733	CbGeAlD
Mepivacaine—Lidocaine—EGFR—prostate cancer	0.00235	0.139	CrCbGaD
Mepivacaine—Bupivacaine—CYP2C19—prostate cancer	0.00231	0.136	CrCbGaD
Mepivacaine—SCN9A—testis—prostate cancer	0.00222	0.0683	CbGeAlD
Mepivacaine—Lidocaine—CYP3A5—prostate cancer	0.00199	0.117	CrCbGaD
Mepivacaine—SCN4A—testis—prostate cancer	0.00198	0.0609	CbGeAlD
Mepivacaine—Lidocaine—CYP2A6—prostate cancer	0.00192	0.114	CrCbGaD
Mepivacaine—Levobupivacaine—CYP3A4—prostate cancer	0.00184	0.108	CrCbGaD
Mepivacaine—SCN3A—bone marrow—prostate cancer	0.0018	0.0554	CbGeAlD
Mepivacaine—SCN9A—lymph node—prostate cancer	0.00161	0.0495	CbGeAlD
Mepivacaine—SCN3A—testis—prostate cancer	0.00154	0.0474	CbGeAlD
Mepivacaine—Bupivacaine—CYP3A4—prostate cancer	0.00147	0.0867	CrCbGaD
Mepivacaine—Tension—Estradiol—prostate cancer	0.00123	0.002	CcSEcCtD
Mepivacaine—Dizziness—Bicalutamide—prostate cancer	0.00123	0.002	CcSEcCtD
Mepivacaine—SCN10A—lymph node—prostate cancer	0.00122	0.0377	CbGeAlD
Mepivacaine—Nervousness—Estradiol—prostate cancer	0.00122	0.00198	CcSEcCtD
Mepivacaine—Back pain—Estradiol—prostate cancer	0.00121	0.00197	CcSEcCtD
Mepivacaine—Hypotension—Goserelin—prostate cancer	0.00121	0.00196	CcSEcCtD
Mepivacaine—Chills—Mitoxantrone—prostate cancer	0.0012	0.00196	CcSEcCtD
Mepivacaine—Hypotension—Conjugated Estrogens—prostate cancer	0.00119	0.00194	CcSEcCtD
Mepivacaine—Atrioventricular block—Doxorubicin—prostate cancer	0.00119	0.00193	CcSEcCtD
Mepivacaine—Ropivacaine—CYP3A4—prostate cancer	0.00118	0.0699	CrCbGaD
Mepivacaine—Vomiting—Bicalutamide—prostate cancer	0.00118	0.00192	CcSEcCtD
Mepivacaine—Tremor—Estradiol—prostate cancer	0.00117	0.00191	CcSEcCtD
Mepivacaine—Erythema—Mitoxantrone—prostate cancer	0.00117	0.0019	CcSEcCtD
Mepivacaine—Headache—Bicalutamide—prostate cancer	0.00116	0.00189	CcSEcCtD
Mepivacaine—Paraesthesia—Goserelin—prostate cancer	0.00116	0.00188	CcSEcCtD
Mepivacaine—Hypersensitivity—Ethinyl Estradiol—prostate cancer	0.00116	0.00188	CcSEcCtD
Mepivacaine—Agitation—Estradiol—prostate cancer	0.00115	0.00187	CcSEcCtD
Mepivacaine—Paraesthesia—Conjugated Estrogens—prostate cancer	0.00115	0.00187	CcSEcCtD
Mepivacaine—Somnolence—Goserelin—prostate cancer	0.00115	0.00187	CcSEcCtD
Mepivacaine—Angioedema—Estradiol—prostate cancer	0.00115	0.00186	CcSEcCtD
Mepivacaine—Somnolence—Conjugated Estrogens—prostate cancer	0.00114	0.00185	CcSEcCtD
Mepivacaine—Back pain—Mitoxantrone—prostate cancer	0.00113	0.00184	CcSEcCtD
Mepivacaine—Asthenia—Ethinyl Estradiol—prostate cancer	0.00113	0.00183	CcSEcCtD
Mepivacaine—Syncope—Estradiol—prostate cancer	0.00112	0.00183	CcSEcCtD
Mepivacaine—SCN3A—lymph node—prostate cancer	0.00112	0.0344	CbGeAlD
Mepivacaine—Pruritus—Ethinyl Estradiol—prostate cancer	0.00111	0.0018	CcSEcCtD
Mepivacaine—Nausea—Bicalutamide—prostate cancer	0.0011	0.00179	CcSEcCtD
Mepivacaine—Loss of consciousness—Estradiol—prostate cancer	0.0011	0.00179	CcSEcCtD
Mepivacaine—Vision blurred—Mitoxantrone—prostate cancer	0.0011	0.00179	CcSEcCtD
Mepivacaine—Cardiac arrest—Prednisone—prostate cancer	0.0011	0.00179	CcSEcCtD
Mepivacaine—Sweating increased—Capecitabine—prostate cancer	0.00109	0.00178	CcSEcCtD
Mepivacaine—Hypertension—Estradiol—prostate cancer	0.00108	0.00176	CcSEcCtD
Mepivacaine—Anxiety—Estradiol—prostate cancer	0.00106	0.00173	CcSEcCtD
Mepivacaine—Dizziness—Ethinyl Estradiol—prostate cancer	0.00104	0.00169	CcSEcCtD
Mepivacaine—Urticaria—Goserelin—prostate cancer	0.00103	0.00167	CcSEcCtD
Mepivacaine—Anaphylactic shock—Estradiol—prostate cancer	0.00102	0.00166	CcSEcCtD
Mepivacaine—Oedema—Estradiol—prostate cancer	0.00102	0.00166	CcSEcCtD
Mepivacaine—Body temperature increased—Goserelin—prostate cancer	0.00102	0.00166	CcSEcCtD
Mepivacaine—Urticaria—Conjugated Estrogens—prostate cancer	0.00102	0.00165	CcSEcCtD
Mepivacaine—Convulsion—Mitoxantrone—prostate cancer	0.00101	0.00165	CcSEcCtD
Mepivacaine—Body temperature increased—Conjugated Estrogens—prostate cancer	0.00101	0.00164	CcSEcCtD
Mepivacaine—Hypertension—Mitoxantrone—prostate cancer	0.00101	0.00164	CcSEcCtD
Mepivacaine—Shock—Estradiol—prostate cancer	0.00101	0.00164	CcSEcCtD
Mepivacaine—Chills—Etoposide—prostate cancer	0.001	0.00163	CcSEcCtD
Mepivacaine—Tachycardia—Estradiol—prostate cancer	0.000999	0.00162	CcSEcCtD
Mepivacaine—Vomiting—Ethinyl Estradiol—prostate cancer	0.000997	0.00162	CcSEcCtD
Mepivacaine—Anxiety—Mitoxantrone—prostate cancer	0.000991	0.00161	CcSEcCtD
Mepivacaine—Hyperhidrosis—Estradiol—prostate cancer	0.000989	0.00161	CcSEcCtD
Mepivacaine—Headache—Ethinyl Estradiol—prostate cancer	0.000982	0.0016	CcSEcCtD
Mepivacaine—Sweating increased—Prednisone—prostate cancer	0.000974	0.00158	CcSEcCtD
Mepivacaine—Anaphylactic shock—Mitoxantrone—prostate cancer	0.000953	0.00155	CcSEcCtD
Mepivacaine—Oedema—Mitoxantrone—prostate cancer	0.000953	0.00155	CcSEcCtD
Mepivacaine—Hypersensitivity—Goserelin—prostate cancer	0.000951	0.00155	CcSEcCtD
Mepivacaine—Hypersensitivity—Conjugated Estrogens—prostate cancer	0.000942	0.00153	CcSEcCtD
Mepivacaine—Back pain—Etoposide—prostate cancer	0.00094	0.00153	CcSEcCtD
Mepivacaine—Shock—Mitoxantrone—prostate cancer	0.000938	0.00153	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Epirubicin—prostate cancer	0.000934	0.00152	CcSEcCtD
Mepivacaine—Nausea—Ethinyl Estradiol—prostate cancer	0.000932	0.00151	CcSEcCtD
Mepivacaine—Tachycardia—Mitoxantrone—prostate cancer	0.00093	0.00151	CcSEcCtD
Mepivacaine—Asthenia—Goserelin—prostate cancer	0.000926	0.00151	CcSEcCtD
Mepivacaine—Hyperhidrosis—Mitoxantrone—prostate cancer	0.000922	0.0015	CcSEcCtD
Mepivacaine—Paraesthesia—Estradiol—prostate cancer	0.000919	0.00149	CcSEcCtD
Mepivacaine—Asthenia—Conjugated Estrogens—prostate cancer	0.000917	0.00149	CcSEcCtD
Mepivacaine—Bradycardia—Capecitabine—prostate cancer	0.000914	0.00149	CcSEcCtD
Mepivacaine—Pruritus—Goserelin—prostate cancer	0.000913	0.00148	CcSEcCtD
Mepivacaine—Somnolence—Estradiol—prostate cancer	0.00091	0.00148	CcSEcCtD
Mepivacaine—Pruritus—Conjugated Estrogens—prostate cancer	0.000905	0.00147	CcSEcCtD
Mepivacaine—Hypotension—Mitoxantrone—prostate cancer	0.000891	0.00145	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Doxorubicin—prostate cancer	0.000865	0.00141	CcSEcCtD
Mepivacaine—Cardiac arrest—Epirubicin—prostate cancer	0.00086	0.0014	CcSEcCtD
Mepivacaine—Lidocaine—CYP3A4—prostate cancer	0.000859	0.0508	CrCbGaD
Mepivacaine—Paraesthesia—Mitoxantrone—prostate cancer	0.000856	0.00139	CcSEcCtD
Mepivacaine—Loss of consciousness—Etoposide—prostate cancer	0.000854	0.00139	CcSEcCtD
Mepivacaine—Dizziness—Goserelin—prostate cancer	0.000854	0.00139	CcSEcCtD
Mepivacaine—Somnolence—Mitoxantrone—prostate cancer	0.000848	0.00138	CcSEcCtD
Mepivacaine—Dizziness—Conjugated Estrogens—prostate cancer	0.000845	0.00137	CcSEcCtD
Mepivacaine—Convulsion—Etoposide—prostate cancer	0.000842	0.00137	CcSEcCtD
Mepivacaine—Hypertension—Etoposide—prostate cancer	0.000839	0.00136	CcSEcCtD
Mepivacaine—Tinnitus—Capecitabine—prostate cancer	0.000837	0.00136	CcSEcCtD
Mepivacaine—Chills—Docetaxel—prostate cancer	0.000832	0.00135	CcSEcCtD
Mepivacaine—Vomiting—Goserelin—prostate cancer	0.000821	0.00133	CcSEcCtD
Mepivacaine—Bradycardia—Prednisone—prostate cancer	0.000814	0.00132	CcSEcCtD
Mepivacaine—Vomiting—Conjugated Estrogens—prostate cancer	0.000813	0.00132	CcSEcCtD
Mepivacaine—Urticaria—Estradiol—prostate cancer	0.000813	0.00132	CcSEcCtD
Mepivacaine—Body temperature increased—Estradiol—prostate cancer	0.000809	0.00132	CcSEcCtD
Mepivacaine—Headache—Goserelin—prostate cancer	0.000809	0.00131	CcSEcCtD
Mepivacaine—Erythema—Docetaxel—prostate cancer	0.000808	0.00131	CcSEcCtD
Mepivacaine—Chills—Capecitabine—prostate cancer	0.000806	0.00131	CcSEcCtD
Mepivacaine—Headache—Conjugated Estrogens—prostate cancer	0.000801	0.0013	CcSEcCtD
Mepivacaine—Cardiac arrest—Doxorubicin—prostate cancer	0.000796	0.00129	CcSEcCtD
Mepivacaine—Anaphylactic shock—Etoposide—prostate cancer	0.000793	0.00129	CcSEcCtD
Mepivacaine—Erythema—Capecitabine—prostate cancer	0.000782	0.00127	CcSEcCtD
Mepivacaine—Back pain—Docetaxel—prostate cancer	0.000781	0.00127	CcSEcCtD
Mepivacaine—Tachycardia—Etoposide—prostate cancer	0.000774	0.00126	CcSEcCtD
Mepivacaine—Nausea—Goserelin—prostate cancer	0.000767	0.00125	CcSEcCtD
Mepivacaine—Hyperhidrosis—Etoposide—prostate cancer	0.000767	0.00125	CcSEcCtD
Mepivacaine—Nausea—Conjugated Estrogens—prostate cancer	0.000759	0.00123	CcSEcCtD
Mepivacaine—Urticaria—Mitoxantrone—prostate cancer	0.000757	0.00123	CcSEcCtD
Mepivacaine—Back pain—Capecitabine—prostate cancer	0.000756	0.00123	CcSEcCtD
Mepivacaine—Hypersensitivity—Estradiol—prostate cancer	0.000754	0.00123	CcSEcCtD
Mepivacaine—Body temperature increased—Mitoxantrone—prostate cancer	0.000754	0.00123	CcSEcCtD
Mepivacaine—Hypotension—Etoposide—prostate cancer	0.000741	0.0012	CcSEcCtD
Mepivacaine—Vision blurred—Capecitabine—prostate cancer	0.000737	0.0012	CcSEcCtD
Mepivacaine—Asthenia—Estradiol—prostate cancer	0.000734	0.00119	CcSEcCtD
Mepivacaine—Tremor—Capecitabine—prostate cancer	0.000732	0.00119	CcSEcCtD
Mepivacaine—Syncope—Docetaxel—prostate cancer	0.000724	0.00118	CcSEcCtD
Mepivacaine—Pruritus—Estradiol—prostate cancer	0.000724	0.00118	CcSEcCtD
Mepivacaine—Paraesthesia—Etoposide—prostate cancer	0.000712	0.00116	CcSEcCtD
Mepivacaine—Loss of consciousness—Docetaxel—prostate cancer	0.00071	0.00115	CcSEcCtD
Mepivacaine—Somnolence—Etoposide—prostate cancer	0.000705	0.00115	CcSEcCtD
Mepivacaine—Hypersensitivity—Mitoxantrone—prostate cancer	0.000702	0.00114	CcSEcCtD
Mepivacaine—Syncope—Capecitabine—prostate cancer	0.000701	0.00114	CcSEcCtD
Mepivacaine—Convulsion—Docetaxel—prostate cancer	0.0007	0.00114	CcSEcCtD
Mepivacaine—Hypertension—Docetaxel—prostate cancer	0.000697	0.00113	CcSEcCtD
Mepivacaine—Drowsiness—Epirubicin—prostate cancer	0.000697	0.00113	CcSEcCtD
Mepivacaine—Erythema—Prednisone—prostate cancer	0.000696	0.00113	CcSEcCtD
Mepivacaine—Loss of consciousness—Capecitabine—prostate cancer	0.000687	0.00112	CcSEcCtD
Mepivacaine—Asthenia—Mitoxantrone—prostate cancer	0.000684	0.00111	CcSEcCtD
Mepivacaine—Dizziness—Estradiol—prostate cancer	0.000677	0.0011	CcSEcCtD
Mepivacaine—Hypertension—Capecitabine—prostate cancer	0.000675	0.0011	CcSEcCtD
Mepivacaine—Sweating—Epirubicin—prostate cancer	0.000668	0.00109	CcSEcCtD
Mepivacaine—Anxiety—Capecitabine—prostate cancer	0.000663	0.00108	CcSEcCtD
Mepivacaine—Anaphylactic shock—Docetaxel—prostate cancer	0.000659	0.00107	CcSEcCtD
Mepivacaine—Oedema—Docetaxel—prostate cancer	0.000659	0.00107	CcSEcCtD
Mepivacaine—Vision blurred—Prednisone—prostate cancer	0.000656	0.00107	CcSEcCtD
Mepivacaine—Vomiting—Estradiol—prostate cancer	0.000651	0.00106	CcSEcCtD
Mepivacaine—Shock—Docetaxel—prostate cancer	0.000648	0.00105	CcSEcCtD
Mepivacaine—Drowsiness—Doxorubicin—prostate cancer	0.000645	0.00105	CcSEcCtD
Mepivacaine—Tachycardia—Docetaxel—prostate cancer	0.000643	0.00105	CcSEcCtD
Mepivacaine—Headache—Estradiol—prostate cancer	0.000641	0.00104	CcSEcCtD
Mepivacaine—Agitation—Prednisone—prostate cancer	0.00064	0.00104	CcSEcCtD
Mepivacaine—Oedema—Capecitabine—prostate cancer	0.000638	0.00104	CcSEcCtD
Mepivacaine—Bradycardia—Epirubicin—prostate cancer	0.000637	0.00104	CcSEcCtD
Mepivacaine—Angioedema—Prednisone—prostate cancer	0.000636	0.00103	CcSEcCtD
Mepivacaine—Urticaria—Etoposide—prostate cancer	0.00063	0.00102	CcSEcCtD
Mepivacaine—Shock—Capecitabine—prostate cancer	0.000628	0.00102	CcSEcCtD
Mepivacaine—Body temperature increased—Etoposide—prostate cancer	0.000627	0.00102	CcSEcCtD
Mepivacaine—Syncope—Prednisone—prostate cancer	0.000625	0.00102	CcSEcCtD
Mepivacaine—Tachycardia—Capecitabine—prostate cancer	0.000623	0.00101	CcSEcCtD
Mepivacaine—Sweating—Doxorubicin—prostate cancer	0.000618	0.00101	CcSEcCtD
Mepivacaine—Hyperhidrosis—Capecitabine—prostate cancer	0.000617	0.001	CcSEcCtD
Mepivacaine—Hypotension—Docetaxel—prostate cancer	0.000616	0.001	CcSEcCtD
Mepivacaine—Loss of consciousness—Prednisone—prostate cancer	0.000612	0.000995	CcSEcCtD
Mepivacaine—Nausea—Estradiol—prostate cancer	0.000608	0.000988	CcSEcCtD
Mepivacaine—Vomiting—Mitoxantrone—prostate cancer	0.000606	0.000986	CcSEcCtD
Mepivacaine—Convulsion—Prednisone—prostate cancer	0.000603	0.000981	CcSEcCtD
Mepivacaine—Hypertension—Prednisone—prostate cancer	0.000601	0.000978	CcSEcCtD
Mepivacaine—Headache—Mitoxantrone—prostate cancer	0.000597	0.000971	CcSEcCtD
Mepivacaine—Hypotension—Capecitabine—prostate cancer	0.000596	0.00097	CcSEcCtD
Mepivacaine—Paraesthesia—Docetaxel—prostate cancer	0.000592	0.000962	CcSEcCtD
Mepivacaine—Anxiety—Prednisone—prostate cancer	0.000591	0.000961	CcSEcCtD
Mepivacaine—Bradycardia—Doxorubicin—prostate cancer	0.000589	0.000958	CcSEcCtD
Mepivacaine—Somnolence—Docetaxel—prostate cancer	0.000586	0.000953	CcSEcCtD
Mepivacaine—Hypersensitivity—Etoposide—prostate cancer	0.000584	0.00095	CcSEcCtD
Mepivacaine—Tinnitus—Epirubicin—prostate cancer	0.000583	0.000949	CcSEcCtD
Mepivacaine—Paraesthesia—Capecitabine—prostate cancer	0.000573	0.000932	CcSEcCtD
Mepivacaine—Asthenia—Etoposide—prostate cancer	0.000569	0.000925	CcSEcCtD
Mepivacaine—Anaphylactic shock—Prednisone—prostate cancer	0.000568	0.000924	CcSEcCtD
Mepivacaine—Oedema—Prednisone—prostate cancer	0.000568	0.000924	CcSEcCtD
Mepivacaine—Nausea—Mitoxantrone—prostate cancer	0.000566	0.000921	CcSEcCtD
Mepivacaine—Chills—Epirubicin—prostate cancer	0.000561	0.000913	CcSEcCtD
Mepivacaine—Pruritus—Etoposide—prostate cancer	0.000561	0.000912	CcSEcCtD
Mepivacaine—Shock—Prednisone—prostate cancer	0.000559	0.000909	CcSEcCtD
Mepivacaine—Tachycardia—Prednisone—prostate cancer	0.000555	0.000902	CcSEcCtD
Mepivacaine—Hyperhidrosis—Prednisone—prostate cancer	0.000549	0.000893	CcSEcCtD
Mepivacaine—Erythema—Epirubicin—prostate cancer	0.000545	0.000886	CcSEcCtD
Mepivacaine—Tinnitus—Doxorubicin—prostate cancer	0.00054	0.000878	CcSEcCtD
Mepivacaine—Tension—Epirubicin—prostate cancer	0.000534	0.000869	CcSEcCtD
Mepivacaine—Nervousness—Epirubicin—prostate cancer	0.000529	0.00086	CcSEcCtD
Mepivacaine—Back pain—Epirubicin—prostate cancer	0.000527	0.000857	CcSEcCtD
Mepivacaine—Dizziness—Etoposide—prostate cancer	0.000524	0.000853	CcSEcCtD
Mepivacaine—Body temperature increased—Docetaxel—prostate cancer	0.000521	0.000847	CcSEcCtD
Mepivacaine—Chills—Doxorubicin—prostate cancer	0.000519	0.000845	CcSEcCtD
Mepivacaine—Vision blurred—Epirubicin—prostate cancer	0.000513	0.000835	CcSEcCtD
Mepivacaine—Paraesthesia—Prednisone—prostate cancer	0.00051	0.00083	CcSEcCtD
Mepivacaine—Urticaria—Capecitabine—prostate cancer	0.000507	0.000824	CcSEcCtD
Mepivacaine—Body temperature increased—Capecitabine—prostate cancer	0.000504	0.00082	CcSEcCtD
Mepivacaine—Vomiting—Etoposide—prostate cancer	0.000504	0.00082	CcSEcCtD
Mepivacaine—Erythema—Doxorubicin—prostate cancer	0.000504	0.000819	CcSEcCtD
Mepivacaine—Agitation—Epirubicin—prostate cancer	0.000501	0.000814	CcSEcCtD
Mepivacaine—Headache—Etoposide—prostate cancer	0.000497	0.000808	CcSEcCtD
Mepivacaine—Tension—Doxorubicin—prostate cancer	0.000495	0.000804	CcSEcCtD
Mepivacaine—Nervousness—Doxorubicin—prostate cancer	0.000489	0.000796	CcSEcCtD
Mepivacaine—Syncope—Epirubicin—prostate cancer	0.000488	0.000794	CcSEcCtD
Mepivacaine—Back pain—Doxorubicin—prostate cancer	0.000487	0.000793	CcSEcCtD
Mepivacaine—Hypersensitivity—Docetaxel—prostate cancer	0.000486	0.00079	CcSEcCtD
Mepivacaine—Loss of consciousness—Epirubicin—prostate cancer	0.000479	0.000778	CcSEcCtD
Mepivacaine—Vision blurred—Doxorubicin—prostate cancer	0.000475	0.000772	CcSEcCtD
Mepivacaine—Asthenia—Docetaxel—prostate cancer	0.000473	0.000769	CcSEcCtD
Mepivacaine—Convulsion—Epirubicin—prostate cancer	0.000472	0.000767	CcSEcCtD
Mepivacaine—Nausea—Etoposide—prostate cancer	0.000471	0.000766	CcSEcCtD
Mepivacaine—Hypertension—Epirubicin—prostate cancer	0.00047	0.000765	CcSEcCtD
Mepivacaine—Hypersensitivity—Capecitabine—prostate cancer	0.00047	0.000764	CcSEcCtD
Mepivacaine—Pruritus—Docetaxel—prostate cancer	0.000466	0.000758	CcSEcCtD
Mepivacaine—Agitation—Doxorubicin—prostate cancer	0.000463	0.000753	CcSEcCtD
Mepivacaine—Anxiety—Epirubicin—prostate cancer	0.000462	0.000751	CcSEcCtD
Mepivacaine—Asthenia—Capecitabine—prostate cancer	0.000458	0.000744	CcSEcCtD
Mepivacaine—Syncope—Doxorubicin—prostate cancer	0.000452	0.000735	CcSEcCtD
Mepivacaine—Urticaria—Prednisone—prostate cancer	0.000452	0.000734	CcSEcCtD
Mepivacaine—Pruritus—Capecitabine—prostate cancer	0.000451	0.000734	CcSEcCtD
Mepivacaine—Body temperature increased—Prednisone—prostate cancer	0.000449	0.000731	CcSEcCtD
Mepivacaine—Oedema—Epirubicin—prostate cancer	0.000445	0.000723	CcSEcCtD
Mepivacaine—Anaphylactic shock—Epirubicin—prostate cancer	0.000445	0.000723	CcSEcCtD
Mepivacaine—Loss of consciousness—Doxorubicin—prostate cancer	0.000443	0.00072	CcSEcCtD
Mepivacaine—Shock—Epirubicin—prostate cancer	0.000437	0.000711	CcSEcCtD
Mepivacaine—Convulsion—Doxorubicin—prostate cancer	0.000437	0.00071	CcSEcCtD
Mepivacaine—Dizziness—Docetaxel—prostate cancer	0.000436	0.000709	CcSEcCtD
Mepivacaine—Hypertension—Doxorubicin—prostate cancer	0.000435	0.000708	CcSEcCtD
Mepivacaine—Tachycardia—Epirubicin—prostate cancer	0.000434	0.000705	CcSEcCtD
Mepivacaine—Hyperhidrosis—Epirubicin—prostate cancer	0.00043	0.000699	CcSEcCtD
Mepivacaine—Anxiety—Doxorubicin—prostate cancer	0.000428	0.000695	CcSEcCtD
Mepivacaine—Dizziness—Capecitabine—prostate cancer	0.000422	0.000686	CcSEcCtD
Mepivacaine—Vomiting—Docetaxel—prostate cancer	0.000419	0.000681	CcSEcCtD
Mepivacaine—Hypersensitivity—Prednisone—prostate cancer	0.000419	0.000681	CcSEcCtD
Mepivacaine—Hypotension—Epirubicin—prostate cancer	0.000415	0.000675	CcSEcCtD
Mepivacaine—Headache—Docetaxel—prostate cancer	0.000413	0.000671	CcSEcCtD
Mepivacaine—Anaphylactic shock—Doxorubicin—prostate cancer	0.000411	0.000669	CcSEcCtD
Mepivacaine—Oedema—Doxorubicin—prostate cancer	0.000411	0.000669	CcSEcCtD
Mepivacaine—Asthenia—Prednisone—prostate cancer	0.000408	0.000663	CcSEcCtD
Mepivacaine—Vomiting—Capecitabine—prostate cancer	0.000406	0.00066	CcSEcCtD
Mepivacaine—Shock—Doxorubicin—prostate cancer	0.000405	0.000658	CcSEcCtD
Mepivacaine—Pruritus—Prednisone—prostate cancer	0.000402	0.000654	CcSEcCtD
Mepivacaine—Tachycardia—Doxorubicin—prostate cancer	0.000401	0.000653	CcSEcCtD
Mepivacaine—Headache—Capecitabine—prostate cancer	0.0004	0.00065	CcSEcCtD
Mepivacaine—Paraesthesia—Epirubicin—prostate cancer	0.000399	0.000649	CcSEcCtD
Mepivacaine—Hyperhidrosis—Doxorubicin—prostate cancer	0.000398	0.000647	CcSEcCtD
Mepivacaine—Somnolence—Epirubicin—prostate cancer	0.000395	0.000643	CcSEcCtD
Mepivacaine—Nausea—Docetaxel—prostate cancer	0.000391	0.000637	CcSEcCtD
Mepivacaine—Hypotension—Doxorubicin—prostate cancer	0.000384	0.000625	CcSEcCtD
Mepivacaine—Nausea—Capecitabine—prostate cancer	0.000379	0.000616	CcSEcCtD
Mepivacaine—Dizziness—Prednisone—prostate cancer	0.000376	0.000611	CcSEcCtD
Mepivacaine—Paraesthesia—Doxorubicin—prostate cancer	0.000369	0.000601	CcSEcCtD
Mepivacaine—Somnolence—Doxorubicin—prostate cancer	0.000366	0.000595	CcSEcCtD
Mepivacaine—Vomiting—Prednisone—prostate cancer	0.000361	0.000588	CcSEcCtD
Mepivacaine—Headache—Prednisone—prostate cancer	0.000356	0.000579	CcSEcCtD
Mepivacaine—Urticaria—Epirubicin—prostate cancer	0.000353	0.000574	CcSEcCtD
Mepivacaine—Body temperature increased—Epirubicin—prostate cancer	0.000351	0.000571	CcSEcCtD
Mepivacaine—Nausea—Prednisone—prostate cancer	0.000338	0.000549	CcSEcCtD
Mepivacaine—Hypersensitivity—Epirubicin—prostate cancer	0.000328	0.000533	CcSEcCtD
Mepivacaine—Urticaria—Doxorubicin—prostate cancer	0.000327	0.000531	CcSEcCtD
Mepivacaine—Body temperature increased—Doxorubicin—prostate cancer	0.000325	0.000529	CcSEcCtD
Mepivacaine—Asthenia—Epirubicin—prostate cancer	0.000319	0.000519	CcSEcCtD
Mepivacaine—Pruritus—Epirubicin—prostate cancer	0.000314	0.000511	CcSEcCtD
Mepivacaine—Hypersensitivity—Doxorubicin—prostate cancer	0.000303	0.000493	CcSEcCtD
Mepivacaine—Asthenia—Doxorubicin—prostate cancer	0.000295	0.00048	CcSEcCtD
Mepivacaine—Dizziness—Epirubicin—prostate cancer	0.000294	0.000478	CcSEcCtD
Mepivacaine—Pruritus—Doxorubicin—prostate cancer	0.000291	0.000473	CcSEcCtD
Mepivacaine—Vomiting—Epirubicin—prostate cancer	0.000283	0.00046	CcSEcCtD
Mepivacaine—Headache—Epirubicin—prostate cancer	0.000278	0.000453	CcSEcCtD
Mepivacaine—Dizziness—Doxorubicin—prostate cancer	0.000272	0.000442	CcSEcCtD
Mepivacaine—Nausea—Epirubicin—prostate cancer	0.000264	0.000429	CcSEcCtD
Mepivacaine—Vomiting—Doxorubicin—prostate cancer	0.000262	0.000425	CcSEcCtD
Mepivacaine—Headache—Doxorubicin—prostate cancer	0.000258	0.000419	CcSEcCtD
Mepivacaine—Nausea—Doxorubicin—prostate cancer	0.000244	0.000397	CcSEcCtD
Mepivacaine—SCN3A—Developmental Biology—PPARA—prostate cancer	0.000217	0.000647	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—ITGB3—prostate cancer	0.000217	0.000646	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—LEP—prostate cancer	0.000215	0.000642	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CASP3—prostate cancer	0.000215	0.00064	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MMP2—prostate cancer	0.000214	0.000637	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP2—prostate cancer	0.000214	0.000637	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MAP2K1—prostate cancer	0.000214	0.000637	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MAP2K1—prostate cancer	0.000214	0.000637	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP2—prostate cancer	0.000213	0.000635	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MAP2K1—prostate cancer	0.000213	0.000634	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—ERBB2—prostate cancer	0.000212	0.00063	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KDR—prostate cancer	0.000211	0.000629	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—JAK2—prostate cancer	0.00021	0.000626	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—PPARA—prostate cancer	0.000209	0.000622	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—PPARA—prostate cancer	0.000209	0.000622	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—prostate cancer	0.000207	0.000616	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—SRC—prostate cancer	0.000207	0.000616	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—LEP—prostate cancer	0.000206	0.000614	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—FGF2—prostate cancer	0.000202	0.000603	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—ERBB2—prostate cancer	0.000202	0.000603	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—JAK2—prostate cancer	0.000202	0.000602	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—JAK2—prostate cancer	0.000202	0.000602	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KDR—prostate cancer	0.000202	0.000601	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—VEGFA—prostate cancer	0.000201	0.0006	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—PPARA—prostate cancer	0.000201	0.000599	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—PPARA—prostate cancer	0.000201	0.000599	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—LEP—prostate cancer	0.000198	0.00059	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—LEP—prostate cancer	0.000198	0.00059	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PRKCQ—prostate cancer	0.000196	0.000585	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—JAK2—prostate cancer	0.000195	0.00058	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—JAK2—prostate cancer	0.000195	0.00058	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—NCOA1—prostate cancer	0.000195	0.00058	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—ERBB2—prostate cancer	0.000194	0.000579	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—ERBB2—prostate cancer	0.000194	0.000579	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—JAK2—prostate cancer	0.000194	0.000578	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KDR—prostate cancer	0.000194	0.000578	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KDR—prostate cancer	0.000194	0.000578	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—EP300—prostate cancer	0.000192	0.000573	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—LEP—prostate cancer	0.000191	0.000569	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—LEP—prostate cancer	0.000191	0.000569	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—ERBB2—prostate cancer	0.000187	0.000558	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—ERBB2—prostate cancer	0.000187	0.000558	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KDR—prostate cancer	0.000187	0.000557	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KDR—prostate cancer	0.000187	0.000557	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—ERBB2—prostate cancer	0.000187	0.000556	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FGF10—prostate cancer	0.000187	0.000556	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—GSK3B—prostate cancer	0.000187	0.000556	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—RXRA—prostate cancer	0.000185	0.000552	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KDR—prostate cancer	0.000184	0.000549	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—INS—prostate cancer	0.000184	0.000548	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—prostate cancer	0.000182	0.000543	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—MMP9—prostate cancer	0.000181	0.000541	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—EGFR—prostate cancer	0.000181	0.00054	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CREBBP—prostate cancer	0.00018	0.000537	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—VAV3—prostate cancer	0.00018	0.000536	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—GSK3B—prostate cancer	0.000178	0.000532	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—INS—prostate cancer	0.000176	0.000524	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—MMP9—prostate cancer	0.000174	0.000517	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CREBBP—prostate cancer	0.000172	0.000514	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP2—prostate cancer	0.000172	0.000513	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MAP2K1—prostate cancer	0.000172	0.000513	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—GSK3B—prostate cancer	0.000171	0.000511	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—GSK3B—prostate cancer	0.000171	0.000511	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—KRAS—prostate cancer	0.000171	0.00051	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—INS—prostate cancer	0.000169	0.000504	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—INS—prostate cancer	0.000169	0.000504	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—SRC—prostate cancer	0.000167	0.000498	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—MMP9—prostate cancer	0.000167	0.000497	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—MMP9—prostate cancer	0.000167	0.000497	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CREBBP—prostate cancer	0.000166	0.000494	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CREBBP—prostate cancer	0.000166	0.000494	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—GSK3B—prostate cancer	0.000165	0.000493	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—GSK3B—prostate cancer	0.000165	0.000493	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP2—prostate cancer	0.000165	0.000491	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MAP2K1—prostate cancer	0.000165	0.00049	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—FGF2—prostate cancer	0.000164	0.000488	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—CTNNB1—prostate cancer	0.000163	0.000487	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—INS—prostate cancer	0.000163	0.000486	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—INS—prostate cancer	0.000163	0.000486	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—VEGFA—prostate cancer	0.000163	0.000485	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—GSK3B—prostate cancer	0.000163	0.000485	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—MMP9—prostate cancer	0.000161	0.000479	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—MMP9—prostate cancer	0.000161	0.000479	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—MMP9—prostate cancer	0.00016	0.000477	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—LPL—prostate cancer	0.00016	0.000477	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—SRC—prostate cancer	0.00016	0.000477	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CREBBP—prostate cancer	0.00016	0.000476	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CREBBP—prostate cancer	0.00016	0.000476	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP2—prostate cancer	0.000158	0.000472	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP2—prostate cancer	0.000158	0.000472	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MAP2K1—prostate cancer	0.000158	0.000471	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MAP2K1—prostate cancer	0.000158	0.000471	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—JAK2—prostate cancer	0.000157	0.000467	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—FGF2—prostate cancer	0.000157	0.000466	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—VEGFA—prostate cancer	0.000156	0.000464	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ITGB3—prostate cancer	0.000155	0.000461	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—SRC—prostate cancer	0.000154	0.000458	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—SRC—prostate cancer	0.000154	0.000458	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP2—prostate cancer	0.000153	0.000455	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP2—prostate cancer	0.000153	0.000455	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MAP2K1—prostate cancer	0.000152	0.000454	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MAP2K1—prostate cancer	0.000152	0.000454	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—EP300—prostate cancer	0.000152	0.000452	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—ERBB2—prostate cancer	0.000151	0.00045	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP2—prostate cancer	0.00015	0.000448	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—FGF2—prostate cancer	0.00015	0.000448	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—FGF2—prostate cancer	0.00015	0.000448	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MAP2K1—prostate cancer	0.00015	0.000447	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—JAK2—prostate cancer	0.00015	0.000447	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—VEGFA—prostate cancer	0.00015	0.000446	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—VEGFA—prostate cancer	0.00015	0.000446	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—SRC—prostate cancer	0.000148	0.000442	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—SRC—prostate cancer	0.000148	0.000442	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—SRC—prostate cancer	0.000148	0.00044	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—EGFR—prostate cancer	0.000147	0.000437	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—FGF2—prostate cancer	0.000145	0.000432	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—FGF2—prostate cancer	0.000145	0.000432	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—ERBB2—prostate cancer	0.000144	0.00043	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—VEGFA—prostate cancer	0.000144	0.00043	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—VEGFA—prostate cancer	0.000144	0.00043	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—JAK2—prostate cancer	0.000144	0.000429	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—JAK2—prostate cancer	0.000144	0.000429	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—VEGFA—prostate cancer	0.000144	0.000428	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—STAT3—prostate cancer	0.000142	0.000424	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—PPARA—prostate cancer	0.000141	0.000421	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—EGFR—prostate cancer	0.00014	0.000418	CbGpPWpGaD
Mepivacaine—SCN8A—Axon guidance—IL6—prostate cancer	0.000139	0.000415	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—JAK2—prostate cancer	0.000139	0.000414	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—JAK2—prostate cancer	0.000139	0.000414	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—ERBB2—prostate cancer	0.000139	0.000413	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—ERBB2—prostate cancer	0.000139	0.000413	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—KRAS—prostate cancer	0.000139	0.000413	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—JAK2—prostate cancer	0.000137	0.000408	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—EGFR—prostate cancer	0.000135	0.000401	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—EGFR—prostate cancer	0.000135	0.000401	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—LEP—prostate cancer	0.000134	0.0004	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—ERBB2—prostate cancer	0.000134	0.000399	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—ERBB2—prostate cancer	0.000134	0.000399	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—KRAS—prostate cancer	0.000132	0.000395	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—CTNNB1—prostate cancer	0.000132	0.000394	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—TGFB1—prostate cancer	0.000132	0.000393	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—ERBB2—prostate cancer	0.000132	0.000393	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KDR—prostate cancer	0.000131	0.000392	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—EGFR—prostate cancer	0.00013	0.000387	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—EGFR—prostate cancer	0.00013	0.000387	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—MMP9—prostate cancer	0.000129	0.000386	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—EGFR—prostate cancer	0.000129	0.000385	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—KRAS—prostate cancer	0.000127	0.000379	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—KRAS—prostate cancer	0.000127	0.000379	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—CTNNB1—prostate cancer	0.000126	0.000376	CbGpPWpGaD
Mepivacaine—SCN5A—SIDS Susceptibility Pathways—IL6—prostate cancer	0.000126	0.000375	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—MMP9—prostate cancer	0.000124	0.000369	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EP300—prostate cancer	0.000123	0.000366	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—KRAS—prostate cancer	0.000123	0.000366	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—KRAS—prostate cancer	0.000123	0.000366	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—KRAS—prostate cancer	0.000122	0.000364	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—CTNNB1—prostate cancer	0.000121	0.000362	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—CTNNB1—prostate cancer	0.000121	0.000362	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—SRC—prostate cancer	0.000119	0.000356	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—MMP9—prostate cancer	0.000119	0.000355	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—MMP9—prostate cancer	0.000119	0.000355	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EP300—prostate cancer	0.000117	0.00035	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—CTNNB1—prostate cancer	0.000117	0.000349	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—CTNNB1—prostate cancer	0.000117	0.000349	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—VEGFA—prostate cancer	0.000116	0.000346	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—GSK3B—prostate cancer	0.000116	0.000346	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—STAT3—prostate cancer	0.000115	0.000343	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—MMP9—prostate cancer	0.000115	0.000342	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—MMP9—prostate cancer	0.000115	0.000342	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—INS—prostate cancer	0.000115	0.000342	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—SRC—prostate cancer	0.000114	0.00034	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—MMP9—prostate cancer	0.000113	0.000337	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EP300—prostate cancer	0.000113	0.000336	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—EP300—prostate cancer	0.000113	0.000336	CbGpPWpGaD
Mepivacaine—SCN9A—Axon guidance—IL6—prostate cancer	0.000113	0.000336	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CREBBP—prostate cancer	0.000112	0.000335	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—VEGFA—prostate cancer	0.000111	0.000331	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—STAT3—prostate cancer	0.00011	0.000328	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—SRC—prostate cancer	0.00011	0.000327	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—SRC—prostate cancer	0.00011	0.000327	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—EP300—prostate cancer	0.000109	0.000324	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EP300—prostate cancer	0.000109	0.000324	CbGpPWpGaD
Mepivacaine—SCN3A—Axon guidance—IL6—prostate cancer	0.000108	0.000321	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP2—prostate cancer	0.000107	0.00032	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MAP2K1—prostate cancer	0.000107	0.000319	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—VEGFA—prostate cancer	0.000107	0.000318	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—VEGFA—prostate cancer	0.000107	0.000318	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—TGFB1—prostate cancer	0.000107	0.000318	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—STAT3—prostate cancer	0.000106	0.000315	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—STAT3—prostate cancer	0.000106	0.000315	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—SRC—prostate cancer	0.000106	0.000315	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—SRC—prostate cancer	0.000106	0.000315	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—EGFR—prostate cancer	0.000105	0.000312	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—SRC—prostate cancer	0.000104	0.000311	CbGpPWpGaD
Mepivacaine—SCN2A—Axon guidance—IL6—prostate cancer	0.000104	0.000309	CbGpPWpGaD
Mepivacaine—SCN4A—Axon guidance—IL6—prostate cancer	0.000104	0.000309	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—VEGFA—prostate cancer	0.000103	0.000307	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—VEGFA—prostate cancer	0.000103	0.000307	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—TGFB1—prostate cancer	0.000102	0.000304	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—STAT3—prostate cancer	0.000102	0.000304	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—STAT3—prostate cancer	0.000102	0.000304	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—FGF2—prostate cancer	0.000102	0.000304	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—VEGFA—prostate cancer	0.000101	0.000302	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—EGFR—prostate cancer	0.0001	0.000298	CbGpPWpGaD
Mepivacaine—SCN1A—Axon guidance—IL6—prostate cancer	9.98e-05	0.000298	CbGpPWpGaD
Mepivacaine—SCN10A—Axon guidance—IL6—prostate cancer	9.98e-05	0.000298	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—IL6—prostate cancer	9.94e-05	0.000296	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—KRAS—prostate cancer	9.88e-05	0.000295	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—TGFB1—prostate cancer	9.81e-05	0.000292	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—TGFB1—prostate cancer	9.81e-05	0.000292	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—JAK2—prostate cancer	9.77e-05	0.000291	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—EGFR—prostate cancer	9.61e-05	0.000286	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—EGFR—prostate cancer	9.61e-05	0.000286	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—TGFB1—prostate cancer	9.46e-05	0.000282	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—TGFB1—prostate cancer	9.46e-05	0.000282	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—KRAS—prostate cancer	9.45e-05	0.000282	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—ERBB2—prostate cancer	9.4e-05	0.00028	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—EGFR—prostate cancer	9.27e-05	0.000276	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—EGFR—prostate cancer	9.27e-05	0.000276	CbGpPWpGaD
Mepivacaine—SCN8A—Developmental Biology—AKT1—prostate cancer	9.17e-05	0.000273	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—EGFR—prostate cancer	9.13e-05	0.000272	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—KRAS—prostate cancer	9.08e-05	0.000271	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—KRAS—prostate cancer	9.08e-05	0.000271	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—KRAS—prostate cancer	8.76e-05	0.000261	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—KRAS—prostate cancer	8.76e-05	0.000261	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—KRAS—prostate cancer	8.63e-05	0.000257	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—CTNNB1—prostate cancer	8.23e-05	0.000245	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—MMP9—prostate cancer	8.07e-05	0.00024	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—IL6—prostate cancer	8.04e-05	0.00024	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—IL6—prostate cancer	7.69e-05	0.000229	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EP300—prostate cancer	7.65e-05	0.000228	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—SRC—prostate cancer	7.44e-05	0.000222	CbGpPWpGaD
Mepivacaine—SCN9A—Developmental Biology—AKT1—prostate cancer	7.42e-05	0.000221	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—IL6—prostate cancer	7.39e-05	0.00022	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—IL6—prostate cancer	7.39e-05	0.00022	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—VEGFA—prostate cancer	7.24e-05	0.000216	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—STAT3—prostate cancer	7.17e-05	0.000214	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—IL6—prostate cancer	7.13e-05	0.000212	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—IL6—prostate cancer	7.13e-05	0.000212	CbGpPWpGaD
Mepivacaine—SCN3A—Developmental Biology—AKT1—prostate cancer	7.1e-05	0.000211	CbGpPWpGaD
Mepivacaine—SCN5A—Axon guidance—IL6—prostate cancer	7.02e-05	0.000209	CbGpPWpGaD
Mepivacaine—SCN2A—Developmental Biology—AKT1—prostate cancer	6.82e-05	0.000203	CbGpPWpGaD
Mepivacaine—SCN4A—Developmental Biology—AKT1—prostate cancer	6.82e-05	0.000203	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—TGFB1—prostate cancer	6.65e-05	0.000198	CbGpPWpGaD
Mepivacaine—SCN10A—Developmental Biology—AKT1—prostate cancer	6.57e-05	0.000196	CbGpPWpGaD
Mepivacaine—SCN1A—Developmental Biology—AKT1—prostate cancer	6.57e-05	0.000196	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—EGFR—prostate cancer	6.52e-05	0.000194	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—KRAS—prostate cancer	6.16e-05	0.000183	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—IL6—prostate cancer	5.01e-05	0.000149	CbGpPWpGaD
Mepivacaine—SCN5A—Developmental Biology—AKT1—prostate cancer	4.62e-05	0.000138	CbGpPWpGaD
